Any feedback?
Literature summary for 2.7.11.22 extracted from
- Explaining the inhibition of cyclin-dependent kinase 5 by peptides derived from p25 with molecular dynamics simulations and MM-PBSA (2010), J. Mol. Model., 16, 1-8.
Activating Compound
| Activating Compound | Comment | Organism | Structure |
|---|---|---|---|
| p35 | activator protein of CDK5 | Homo sapiens |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| CIP (154-279) | - |
Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| ATP + tau protein | - |
Homo sapiens | ADP + phosphorylated tau protein | - |
? |  |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| Cdk5 | - |
Homo sapiens |
| cyclin-dependent kinase 5 | - |
Homo sapiens |
Cofactor
| Cofactor | Comment | Organism | Structure |
|---|---|---|---|
| ATP | - |
Homo sapiens | |
| cyclin | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
